{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:28:36Z","timestamp":1777984116986,"version":"3.51.4"},"reference-count":19,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,8,3]]},"abstract":"<jats:p>Chronic myeloid leukaemia (CML) is a myeloproliferative disorder with an incidence of 1\u20132 cases per 100\u2009000 adults per year.<jats:sup>1<\/jats:sup>Since the International Randomized Study of Interferon and STI571 trial (IRIS trial) in 2003, treatment with tyrosine kinase inhibitors (TKIs) has become the standard of care for patients with newly diagnosed CML in the chronic phase.<jats:sup>2<\/jats:sup>Dasatinib is a second-generation TKI and is generally well tolerated, with cytopenias, gastrointestinal (GI) symptoms and fluid retention being the most commonly observed side effects.<jats:sup>3\u20135<\/jats:sup>Bleeding complications, although unusual, have been reported with dasatinib, with an incidence ranging from 8% to 24%.<jats:sup>3\u20136<\/jats:sup>The most commonly reported site of bleeding is the GI tract.<jats:sup>3 5<\/jats:sup>We report an unusual case of dasatinib-associated bleeding presenting with acute bilateral hyphemas, which, to our knowledge, is the first report of its kind.<\/jats:p>","DOI":"10.1136\/bcr-2018-225705","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T15:37:00Z","timestamp":1535384220000},"page":"bcr-2018-225705","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Unusual case of dasatinib-associated acute bilateral hyphemas leading to blindness in a patient with chronic myeloid leukaemia"],"prefix":"10.1136","volume":"2018","author":[{"given":"Sandhya","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina M","family":"Ghiuzeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,8,27]]},"reference":[{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24275"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022457"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24257"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055229"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-09-046888"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.6","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3109\/09537104.2015.1049138","article-title":"Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: case report","volume":"26","author":"Kostos","year":"2015","journal-title":"Platelets"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.7","first-page":"1","article-title":"First-line therapy for chronic phase CML: selecting the optimal BCR-ABL 1 \u2013targeted TKI","volume":"3","author":"Saglio","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(02)00317-X"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.9","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.2147\/DDDT.S85050","article-title":"Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations","volume":"10","author":"Keskin","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/417106","article-title":"Haemorrhagic colitis caused by dasatinib","volume":"2012","author":"Patodi","year":"2012","journal-title":"Case Rep Hematol"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.11","unstructured":"Kiel JW . Chapter 2, Anatomy. The ocular circulation. San Rafael (CA): Morgan & Claypool Life Sciences, 2010."},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-205328"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-326850"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0667"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-02-204693"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(99)00099-5"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.17","doi-asserted-by":"publisher","DOI":"10.1002\/hon.822"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.18","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.5"},{"key":"2025042706041814000_2018.aug27_1.bcr-2018-225705.19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.7522"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-225705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T13:04:28Z","timestamp":1745759068000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-225705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,27]]},"references-count":19,"alternative-id":["10.1136\/bcr-2018-225705"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-225705","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,27]]}}}